Skip to main content
. 2006 Jun 8;3(3):359–364. doi: 10.1093/ecam/nel025

Figure 1.

Figure 1

Plasma levels of sE-selectin (A), sICAM-1 (B), and sVCAM-1 (C) at baseline and 12 weeks after administration of KBG. Data represent mean ± SE (n = 14), *P < 0.01 compared with baseline.